Originally published by our sister publication Infectious Disease Special Edition
By Marie Rosenthal, MS
Because it rises early after an infectious insult, interleukin-6 (IL-6) may be an effective biomarker for predicting sepsis in high-risk patients, including neonates, children and pregnant women, said Seán O. Whelan, MB, BAO, BCh, BSc, MSc, MRCPI, at ESCMID Global 2025, in Vienna (abstract O0177).
Managing sepsis is a race against time, so the clinical diagnosis of sepsis is always a